Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(30 sites) United States
Emory University, Atlanta, Georgia Riley Hospital for Children, Indianapolis, Indiana University of Minnesota Masonic Childrens Hospital Discovery Clinic, Minneapolis, Minnesota Cohen Children Medical Center, Lake Success, New York University of North Carolina, Chapel Hill, North Carolina Wake Forest University Health Sciences, Charlotte, North Carolina Akron Childrens Hospital, Akron, Ohio Cleveland Clinic Foundation, Cleveland, Ohio University of Pittsburgh Medical Center Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania Texas Childrens Hospital, Houston, Texas Belgium
Universitair Ziekenhuis Gent, Ghent Universitair Ziekenhuis Leuven - Gasthuisberg, Leuven Canada
Alberta Childrens Hospital, Calgary, Alberta Stollery Childrens Hospital, Edmonton, Alberta CHU Sainte Justine, Montreal, Quebec Czechia
Vseobecna fakultni nemocnice v Praze, Prague Fakultni nemocnice v Motole, Prague France
Centre Hospitalier Universitaire de Bordeaux - Hopital Pellegrin, Bordeaux Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron Hopital Necker Enfants Malades, Paris Hungary
Semmelweis Egyetem, Budapest Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged Poland
Uniwersyteckie Centrum Kliniczne, Gdansk Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow Dzieciecy Szpital Kliniczny im. Jozefa Polikarpa Brudzinskiego w Warszawie, Warsaw Slovakia
Narodny ustav detskych chorob, Bratislava Spain
Hospital Universitari Vall d Hebron, Barcelona, Catalonia Hospital Sant Joan de Deu, Esplugues de Llobregat, Catalonia Hospital Universitario 12 de Octubre, Madrid